Sarango-Quishpe Kuri Tupak, Cabrera-Padrón María Isabel, Torracchi-Carrasco José Esteban, Andrade-Medina Gloria, Juela-Moscoso Cesar Heriberto
College of Dentistry, Catholic University of Cuenca, Cuenca, Ecuador.
Center for Research, Innovation and Technology Transfer (CIITT), Catholic University of Cuenca, Cuenca, Ecuador.
Korean J Orthod. 2025 Mar 25;55(2):120-130. doi: 10.4041/kjod24.049. Epub 2024 Dec 2.
Orthodontic appliances are commonly used to achieve anchorage during orthodontic treatments; however, their use can contribute to oral diseases. Studies have shown that bisphosphonates and osteoprotegerin are highly effective in reducing orthodontic tooth movement. To determine the efficacy of bisphosphonates and osteoprotegerin in reducing orthodontic tooth movement.
A comprehensive search was conducted across five databases-MEDLINE-PubMed, Scopus, Google Scholar, ScienceDirect, and Taylor & Francis-up to August 2, 2023. Clinical trials conducted in healthy animals, where bisphosphonates and osteoprotegerin were administered during tooth movement, were included. The search identified 3,099 articles, which underwent a two-phase screening process, resulting in twelve studies for the systematic review and seven for the meta-analysis. Risk of bias was assessed using the SYRCLE tool, and Egger's regression was used to evaluate publication bias.
The administration of bisphosphonates was more effective than osteoprotegerin in reducing mesiodistal orthodontic movement. However, osteoprotegerin did not significantly reduce orthodontic tooth movement.
The findings align with previous studies, confirming the superior efficacy of bisphosphonates over osteoprotegerin. Further research is required to determine the optimal dosage and mechanism of action for these drugs in clinical practice, considering the specific objectives of orthodontic treatments.
正畸矫治器在正畸治疗中常用于实现支抗;然而,其使用可能会引发口腔疾病。研究表明,双膦酸盐和骨保护素在减少正畸牙齿移动方面非常有效。旨在确定双膦酸盐和骨保护素在减少正畸牙齿移动方面的疗效。
截至2023年8月2日,在五个数据库——MEDLINE-PubMed、Scopus、谷歌学术、ScienceDirect和泰勒与弗朗西斯——中进行了全面检索。纳入在健康动物中进行的临床试验,这些试验在牙齿移动期间给予双膦酸盐和骨保护素。检索共识别出3099篇文章,这些文章经过两阶段筛选过程,最终有12项研究用于系统评价,7项研究用于荟萃分析。使用SYRCLE工具评估偏倚风险,并使用Egger回归评估发表偏倚。
在减少近远中向正畸移动方面,双膦酸盐的给药比骨保护素更有效。然而,骨保护素并未显著减少正畸牙齿移动。
这些发现与先前的研究一致,证实了双膦酸盐比骨保护素具有更高的疗效。考虑到正畸治疗的具体目标,需要进一步研究以确定这些药物在临床实践中的最佳剂量和作用机制。